Results
Displaying results 41 to 60 out of 329
Filters
![](https://www.rhsupplies.org/typo3temp/assets/images/1864145f37.png)
Published in 2023
The Importance of Political Economy Analysis for Strengthening Health Commodity Supply Chains: A Primer
USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/442af39e1d.png)
Published in 2023
Helping Mothers Survive Bleeding After Birth Complete: ACTION PLAN
USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/882e0613a2.png)
Published in 1994
An Assessment of the need for contraceptive introduction in Brazil
WHO Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/d0e5f93f5c.png)
Published in 2009
PRODOPS Professional Development Opportunities for Public Sector Reproductive Health Commodity Managers - Final Activity Report
RHSC: General RHSC: Innovation Fund
![](https://www.rhsupplies.org/typo3temp/assets/images/cd996d14de.png)
Published in 2022
Ley Cenabast y anticoncepción: información y beneficios para consumidoras
RHSC: General
![](https://www.rhsupplies.org/typo3temp/assets/images/fb997f2a48.png)
Published in 2022
Médicaments pour la prévention et le traitement de l’hémorragie du post-partum et d’autres indications obstétricales
RHSC: General USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/e7d8f3b69c.png)
Published in 2009
Atteindre les OMDs: La contribution de la planification familiale: Burkina Faso
RHSC: General
![](https://www.rhsupplies.org/typo3temp/assets/images/6c6ac1a750.png)
Published in 2004
Processes and Issues for Improving Access to Medicines- The evidence base for domestic production and greater access to medicines
DFID Health Resource Centre
![](https://www.rhsupplies.org/typo3temp/assets/images/096580811a.png)
Published in 2009
Contraceptive Security in Nigeria: Assessing Strengths and Weaknesses
DELIVER Country Report DELIVER Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/746cda1622.png)
Published in 2004
Access to Medicines in Under-served Markets: What are the implications of changes in intellectual property rights, trade and drug registration policy?
DFID Health Resource Centre